- Poster presentation
- Open Access
Etomidate versus ketamine for rapid sequence intubation in acutely ill patients: a multicenter randomized controlled trial
Critical Care volume 13, Article number: P405 (2009)
Critically ill patients often require emergency intubation with administration of etomidate as the sedative agent. The use of etomidate has been challenged as it causes a reversible adrenal insufficiency probably leading to an increase in hospital morbidity.
In this prospective, randomized, controlled, single-blind trial, we assigned 234 patients to receive 0.3 mg/kg etomidate and 235 patients to receive 2 mg/kg ketamine for intubation. The primary endpoint was the maximum value of the Sequential Organ Failure Assessment score (SOFAmax) during the first inhospital 3 days. (ClinicalTrials.gov number, NCT00440102.)
The mean SOFAmax score between the two groups was not significantly different (10.3 ± 3.7 for etomidate vs. 9.6 ± 3.9 for ketamine; P = 0.056). There was no significant difference in 28-day mortality (81 (35%) deaths vs. 72 (31%) deaths, P = 0.36), the number of patients needing catecholamine (137 (59%) patients vs. 120 (51%) patients, P = 0.10), median (IQR) ventilator-free days (12 (0 to 25) days vs. 15 (0 to 26) days, P = 0.36) and median (IQR) hospital-free days (4 (0 to 22) days vs. 6 (0 to 23) days, P = 0.57). Adrenal insufficiency incidence was significantly higher in etomidate than ketamine group (86% vs. 48%, P < 0.001). There was no significant difference between the two groups in intubation conditions. There was no significant difference in outcome between the etomidate and ketamine groups on prespecified subgroup analysis (trauma or sepsis patients).
Our results do not provide evidence for contra-indicating etomidate during emergency intubation in critically ill patients. However, ketamine can constitute a good alternative.
About this article
Cite this article
Jabre, P., Combes, X., Ricard-Hibon, A. et al. Etomidate versus ketamine for rapid sequence intubation in acutely ill patients: a multicenter randomized controlled trial. Crit Care 13, P405 (2009). https://doi.org/10.1186/cc7569
- Sequential Organ Failure Assessment
- Adrenal Insufficiency